Respiratory mucous secretion and mucociliary clearance pathways (MCC)

The respiratory mucous secretion and mucociliary clearance (MCC) pathways constitute the primary physical defense mechanism of the conducting airways (StatPearls: Physiology, Mucociliary Clearance). This integrated system relies on the production of a complex gel-like mucus by goblet cells and submucosal glands to trap inhaled particles, pathogens, and toxins (NIH: Airway Mucus and Mucociliary Clearance). The mucus is then propelled cephalad toward the pharynx by the rhythmic, coordinated beating of cilia on the apical surface of the airway epithelium, a process often referred to as the 'mucociliary escalator' (PubMed: Mucociliary clearance in health and disease). Proper functioning of this pathway is highly dependent on the rheological properties of the mucus and the depth of the periciliary liquid layer, which are regulated by ion transport proteins such as the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and the Epithelial Sodium Channel (ENaC). Impairment of MCC is a central feature in the pathogenesis of various obstructive lung diseases, including cystic fibrosis, chronic obstructive pulmonary disease (COPD), and bronchiectasis, where mucus stasis leads to chronic inflammation and recurrent infections. Pharmacological strategies targeting these pathways include mucolytics to reduce mucus viscosity, expectorants to increase secretion volume, and ion channel modulators to improve airway hydration.

Other names

Mucociliary escalatorMucociliary apparatusAirway clearance mechanismsMucus production and clearance

Mucolytics reduce mucus viscosity by breaking disulfide bonds; expectorants increase the volume of airway secretions; CFTR modulators improve airway surface liquid hydration; beta-agonists stimulate ciliary beat frequency.